News

Press Releases

Scientific Presentations

February 22, 2022

Capillary Biomedical Receives

ISO 13485:2016 Quality System Certification

June 4, 2022

“Progressive Acceleration Of Insulin Exposure Over 7 Days Of Infusion Set Wear” presented at ADA’s 82nd Scientific Sessions

June 29, 2021

“Feasibility of an Investigational Extended Wear Infusion Set for Insulin Pump Therapy (IPT) in People with Type 1 Diabetes Mellitus.” presented at ADA’s 81st Scientific Sessions

January 19, 2022

Capillary Biomedical Receives FDA Approval to Begin Pivotal Trial of its SteadiFlow Seven-Day-Wear Infusion Set Technology

February 20, 2020

“Novel Kink-Resistant Insulin Infusion Set Causes Significantly Less Subcutaneous Tissue Inflammation Compared with a Straight Teflon Insulin Infusion Set” presented at the 13th International Conference on Advanced Technologies & Treatments for Diabetes

February 21, 2019

“Histological Comparison of Tissue Response to Investigational and Commercially-Available Continuous Subcutaneous Insulin Infusion (CSII) Sets in Live Swine” presented at the 12th International Conference on Advanced Technologies & Treatments for Diabetes

June 29, 2021

Capillary Biomedical Reports Best-in-Class Clinical Feasibility Results for its SteadiFlow Seven-Day-Wear Infusion Set Technology at ADA Scientific Sessions

June 22, 2018

“Micro-CT Imaging of an Insulin Bolus Infusion Through Continuous Subcutaneous Insulin Infusion (CSII) Sets in Live Swine: Quantitative Comparison of Distribution Patterns in Tissue Over Eight Days.” presented at ADA’s 78th Scientific Sessions

February 14, 2018

“Histological Comparison of Tissue Response for Stainless Steel and Teflon Continuous Subcutaneous Insulin Infusion (CSII) Catheters in Live Swine” presented at the 11th International Conference on Advanced Technologies & Treatments for Diabetes

October 7, 2020

Capillary Biomedical Receives

$1.5 Million from Helmsley Charitable Trust for Clinical Trials of New Insulin Infusion Technology

June 13, 2017

“Micro-CT Imaging of an Insulin Bolus Infusion Through Commercial Continuous Subcutaneous Insulin Infusion (CSII) Catheters in Live Swine: A Time Course Study of Distribution Patterns” presented at ADA’s 77th Scientific Sessions

July 6, 2016

“Tissue Histology Surrounding Continuous Subcutaneous Insulin Infusion (CSII) Catheters Implanted in Canines for 7 Days” presented at NIH’s Fourth Artificial Pancreas Workshop

August 14, 2018

Capillary Biomedical Closes

$2.9 Million Series Seed Financing for Commercialization of Novel Insulin Infusion Technology

October 22, 2015

“Optimization of Insulin Delivery through a CSII Catheter” presented at 15th Annual Diabetes Technology Meeting

June 13, 2017

Capillary Biomedical Sheds Light on the Mechanical Challenges of Insulin Pump Delivery Systems at Annual ADA Scientific Sessions

August 3, 2016

Capillary Biomedical Developing Improved Insulin Delivery Catheter with Funding Support from JDRF